Evidence map›Paper›PMID 20011437›Full record

ArticleClinics in colon and rectal surgery2008

Extracolonic manifestations of hereditary colorectal cancer syndromes.

Daniel A Anaya, George J Chang, Miguel A Rodriguez-Bigas

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Clinics in colon and rectal surgery, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04168931 (Efficacy of Adding Trastuzumab to Standard Chemotherapy in Patients With Advanced HER2-negative Gastric Cancer and HER2 Positive Expression in Circulating Tumor Cells), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04168931 phase2terminatednot on this mapstarted 2020, after this paper: background citation

Efficacy of Adding Trastuzumab to Standard Chemotherapy in Patients With Advanced HER2-negative Gastric Cancer and HER2 Positive Expression in Circulating Tumor Cells

TypeinterventionalSponsorAC Camargo Cancer CenterRan2020 to 2023Enrolled5ConditionsGastric Cancer Stage IVArmsTrastuzumab
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. How many is too many? Polyposis syndromes and what to do next.Current opinion in gastroenterology · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. Hereditary Polyposis Syndromes.Current treatment options in gastroenterology · 2019
    Review
  8. Article
  9. Article
  10. Familial Adenomatous Polyposis (FAP)-A Case Study and Review of Literature.Journal of clinical and diagnostic research : JCDR · 2015
    Article
  11. Chemoprevention of colorectal cancer.Digestive diseases (Basel, Switzerland) · 2015
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daniel A AnayaDepartment of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77230, USA.
George J Chang
Miguel A Rodriguez-Bigas
Society of Surgical Oncology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial colorectal adenocarcinoma (CRC) accounts for approximately 15 to 20% of CRC. Of these, hereditary nonpolyposis colorectal cancer (HNPCC) and familial adenomatous polyposis (FAP) represent the most common hereditary syndromes associated with CRC, followed by other less common diseases including juvenile polyposis (JP) and Peutz-Jeghers syndrome (PJS). Extracolonic manifestations are common in each of these syndromes having significant implications for surveillance and management in at-risk individuals. The authors review the most common and clinically relevant extracolonic manifestations for each of these syndromes focusing on incidence, presentation, genotype/phenotype correlations, and management (including surveillance) strategies.

Indexed as

colorectal cancerextracolonic manifestationsHereditary polyposis

Identifiers

PMID20011437
PMCPMC2780251
OpenAlexW2049885450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.